Loading data for PLSE — first visit, this takes a few seconds.

Pulse Biosciences, Inc. (PLSE)

NasdaqCM: PLSE · 即時價格 · USD

53.24

-1.47 (-2.69%)

收盤價： Sep 04, 2026, 8:00 PM

53.27

+0.06%

盤後: 7:30 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

無可用資料

買價	53.62
市值	3.8B
營收 (ttm)	1.19M
淨利（ttm）	-80.1M
	1.62
	-1.17
	n/a
	-46.1
P/B (ttm)	37.89
P/S (ttm)	3204.40
財報日期	Nov 5, 2026

賣價	68.1
成交量	515,419
20 日平均成交量	414,596
開盤價	53.68
前收盤價	54.71
當日區間	52.75 - 54.75
52 週範圍	12.56 - 55.37
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 PLSE

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferent...

[閱讀更多]

產業 Medical Instruments & Supplies

類股 Healthcare

IPO 日期 May 18, 2016

員工 116

證券交易所 NasdaqCM

股票代號 PLSE

網站 https://www.pulsebiosciences.com

完整的公司簡介

財務表現

Pulse Biosciences 在 2025 年的營收為 350K，較前一年的 0 增加 undefined%。淨利為 -72.78M，較前期增加 35.82%。

財務報表

財報驚奇

Pulse Biosciences 已於 Aug 6, 2026 公布季度財報：

營收為 $434K 低於預期 $0, 年增 Infinity% 成長.
每股盈餘為 -0.28 低於預期 0.00, 年增 0.00% 成長.

下次財報發布

Pulse Biosciences, Inc. 的下次財報預計於 Nov 5, 2026, 盤中。
分析師預估營收 ... 升級

價格為何變動

新聞動態

3 週前 · Simply Wall St.

Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns

Pulse Biosciences has delivered a very strong share price run, with recent enthusiasm around its atrial fibrillation program now sitting against valuation checks that point to a stock that screens exp...

3 週前 · MarketBeat

Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform

Pulse Biosciences (NASDAQ:PLSE) is positioning its nanosecond pulsed field ablation technology as a potential next-generation treatment platform for atrial fibrillation and other conditions, President...

3 週前 · Simply Wall St.

Pulse Biosciences (PLSE) Prices A $75 Million Offering, Is The Stock Fully Valued?

Pulse Biosciences (PLSE) is back in focus after reporting wider second quarter losses and announcing a $75 million at the market follow on equity offering, a combination that directly affects existing...